NCT04780204View on ClinicalTrials.gov

Effectiveness of Antiviral Treatment in Cirrhotic Patients with Low-level Hepatitis B Virus DNA Levels

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

August 23, 2021

Primary Completion Date

January 31, 2027

Study Completion Date

December 31, 2027

Conditions
Hepatitis B, Chronic
Interventions
DRUG

Treatment

Tenofovir Alafenamide 25 mg oral once daily

Trial Locations (10)

Unknown

Kyungpook National University Hospital, Daegu

Asan Medical Center, Seoul

Chung-Ang University Hospital, Seoul

Konkuk University Hospital, Seoul

Korea University Guro Hospital, Seoul

Kyung-Hee University Hospital, Seoul

Samsung Medical center, Seoul

Seoul National University Bundang Hospital, Seoul

Seoul National University Hospital, Seoul

Ulsan University Hospital, Ulsan

Sponsors
All Listed Sponsors
collaborator

National Evidence-Based Healthcare Collaborating Agency

OTHER_GOV

lead

Asan Medical Center

OTHER

NCT04780204 - Effectiveness of Antiviral Treatment in Cirrhotic Patients with Low-level Hepatitis B Virus DNA Levels | Biotech Hunter | Biotech Hunter